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A Qualitative Systematic Review of the Association of Sleep Disturbances with
Burning Mouth Syndrome: An Overlooked Relationship
Abstract
Objectives: To review the relevant literature to assess if patients with burning mouth syndrome (BMS) are
more prone to have sleep disturbances than general population.
Methods: The literature search for relevant articles was from July 2020 to March 2021. A systematic
search of PubMed, Embase, Google Scholar, Cochrane library, Dentistry & Oral Sciences Source, and
Scopus was conducted to search for relevant studies. The quality of studies was assessed in accordance
with the Joanna Briggs Institute’s guidelines and using the software SUMARI – The System for the Unified
Management, Assessment and Review of Information. Confidence in the findings was assessed using the
GRADE‐CERQual approach.
Results: A total of 1064 studies were initially identified from the search; 6 studies, two cross-sectional and
4 case controls, met the inclusion criteria and were selected for this systematic review. Sleep
disturbances was a required outcome measured in selected studies evaluating symptoms of BMS. For
studies that were included in the final analyses, BMS was found to relate to several dimensions of sleep
including sleep disturbance and duration (n=6), sleep affecting day-time function (n=4), sleep quality
(n=6), sleep efficiency (n=4), and ability to fall asleep (n=4). Consistent evidence of moderate confidence
found that BMS was associated with greater sleep disturbance, reduced sleep quality, increased time
taken to fall asleep, reduced sleep efficiency, and poor day-time function. Whereas evidence of low
confidence was found regarding the association of BMS with reduced sleep duration.
Conclusions: Although the presented studies could not establish a direct causal relationship between
BMS and sleep disturbances, it revealed that sleep disturbance can be a risk factor or/and an aggravator
of BMS symptoms. Medications and psychological management strategies to improve sleep may be
considered in future research for managing BMS patients.
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A Qualitative Systematic Review of the Association of Sleep Disturbances with
Burning Mouth Syndrome: An Overlooked Relationship

Abstract:
Objectives: To review the relevant literature to assess if patients with burning
mouth syndrome (BMS) are more prone to have sleep disturbances than general
population.
Methods: The literature search for relevant articles was from July 2020 to March
2021. A systematic search of PubMed, Embase, Google Scholar, Cochrane library,
Dentistry & Oral Sciences Source, and Scopus was conducted to search for
relevant studies. The quality of studies was assessed in accordance with the
Joanna Briggs Institute’s guidelines and using the software SUMARI – The System
for the Unified Management, Assessment and Review of Information. Confidence
in the findings was assessed using the GRADE‐CERQual approach.
Results: A total of 1064 studies were initially identified from the search; 6 studies,
two cross-sectional and 4 case controls, met the inclusion criteria and were
selected for this systematic review. Sleep disturbances was a required outcome
measured in selected studies evaluating symptoms of BMS. For studies that were
included in the final analyses, BMS was found to relate to several dimensions of
sleep including sleep disturbance and duration (n=6), sleep affecting day-time
function (n=4), sleep quality (n=6), sleep efficiency (n=4), and ability to fall asleep
(n=4). Consistent evidence of moderate confidence found that BMS was
associated with greater sleep disturbance, reduced sleep quality, increased time
taken to fall asleep, reduced sleep efficiency, and poor day-time function.

Whereas evidence of low confidence was found regarding the association of BMS
with reduced sleep duration.
Conclusions: Although the presented studies could not establish a direct causal
relationship between BMS and sleep disturbances, it revealed that sleep
disturbance can be a risk factor or/and an aggravator of BMS symptoms.
Medications and psychological management strategies to improve sleep may be
considered in future research for managing BMS patients.

Introduction
Burning mouth syndrome (BMS), also known as glossodynia, glossalgia,
stomatodynia, stomatopyresis are all terms used to describe chronic pain disorder
of unknown etiology that frequently affects postmenopausal women and it is
characterized by a burning sensation of the oral cavity in the absence of any
identifiable organic disease (1). The etiology of primary BMS is unknown but
recent neurophysiological, psychophysical, neuropathological and brain imaging
studies using recent diagnostic criteria have resulted in advances in the
understanding of the condition’s pathophysiology. There is growing evidence that
primary BMS is of neuropathic origin but there is still a small percentage of BMS
patients who exhibit no abnormalities in neurophysiologic and Quantitative
Sensory Testing (QST) measurements. BMS can be classified into primary or
secondary based on etiology but, to date, this classification has not been
validated (2) and BMS remains a challenging diagnosis of exclusion. Secondary
causes of pain of the oral mucosa that is caused by local or systemic pathologies
such as deficiencies in iron or diabetes should be excluded to give the diagnosis of
primary BMS (3). The evidence also shows that due to variable diagnostic criteria,
the prevalence of BMS occurs between 0.7% and 15% affecting mainly
postmenopausal females with male-to- female ratio of 1:5 to 1:7 (1). Moreover,
prevalence in both males and females seems to increases with age (1). To date,
there is no cure for BMS and there is no standard algorithm for management.
Despite the fact that most cases of BMS appear not to be associated with evident
organic changes, or direct risks to health, BMS can significantly reduce the quality
of life for such patients. Yet, as with all chronic diseases, both physical and
psychological comorbidities occur and should be investigated. Although the

relationship between BMS and depression and anxiety are well documented in
the literature, little is known about the relationship between BMS and sleep
disturbances and whether improvement of sleep quality will improve symptoms
of BMS. As most orofacial pain and oral medicine specialists often overlook the
role of sleep in the genesis and aggravation of BMS symptoms, the present
systematic review seeks to evaluate the relationship of sleep disturbances with
BMS as an important diagnostic component. If such a relationship exists, sleeppromoting medications and other sleep improving strategies may be of help in the
management of BMS patients. Although the current literature establishes a
significant relationship between chronic pain and sleep disturbances, the
association of BMS and sleep is not well studied. Thus, the objective of this review
was to evaluate if patients with BMS are more prone to have sleep disturbances
that needs to be addressed by clinicians to improve treatment outcomes and
overall quality of life of affected individuals.

Materials and Methods
We performed a systematic review of the literature evaluating the association
between sleep disturbance and BMS. The search included studies with different
methodologies including observational studies, such as cross-sectional and case
control studies that were selected according to the criteria outlined below. The
main outcome was to determine if patients with BMS report more sleep
disturbances than general population.
This review considered studies of English literature published before March 2021,
reporting the relationship between BMS and sleep, or BMS studies where sleep
was an outcome measure. Studies who enrolled subjects with the following

criteria were included: adult human males and females, aged 18 years or older
and subjects who had a diagnosis of primary BMS without previous diagnosis of
sleep disorders.
The proposed systematic review was conducted in accordance with the Joanna
Briggs Institute methodology for systematic reviews of qualitative evidence (*1)
and has been registered with (PROSPERO), International Prospective Register of
Systematic Reviews (CRD 42020202650). This review comprised 3 phases. Phase 1
involved a systematic search of the literature based on a combination of
keywords (see section Phase 1: Database Search). Phase 2 involved screening of
literature titles and abstracts using specific inclusion criteria (see inclusion criteria
for systematic review), and full article screening. Finally, Phase 3 involved
classifying the internal validity (quality) of the included studies using established
and valid tools, extraction of data from selected studies, and synthesis of the
evidence.
Phase 1: Search Strategy
The search strategy aimed to find published studies of qualitative and
quantitative methods. However, only the qualitative data from mixed-methods
studies were used in the data analysis. The search strategy was undertaken in
Google Scholar, Cochrane library, Dentistry & Oral Sciences Source, MEDLINE
(PubMed), Scopus (Elsevier), and Embase (Ovid). All identified keywords and
index terms were adapted for each included information source. Databases were
searched for relevant English language articles published from July 2020 to March
2021. Finally, the reference lists of all studies selected for critical appraisal were
screened for additional studies. The main search strategies are provided in
Appendix I.

Phase 2: Study selection
Following the search, all identified citations collated and uploaded into EndNote
X9 (Clarivate Analytics, PA, USA) and duplicates removed. Titles and abstracts
were screened by two independent reviewers (FA and LG) for assessment against
the inclusion criteria defined for the review. Studies that met the inclusion criteria
were retrieved in full and their details imported into the JBI System for the
Unified Management, Assessment and Review of Information (JBI SUMARI; JBI,
Adelaide, Australia) (5). The full text of selected studies was retrieved and
assessed in detail against the inclusion criteria by two independent reviewers (FA
and EK). Full-text studies that did not meet the inclusion criteria were excluded,
and reasons for exclusion were reported in the systematic review. The results of
the search were presented in a Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) flow diagram (*2) (Figure 1). Any disagreements
that arose between the reviewers were resolved through discussion.
Phase 3: Assessment of methodological quality and strength of evidence
Quality of the studies was assessed in accordance with the Joanna Briggs Institute
(JBI) guidelines. Two independent reviewers (FA and EK) utilized the JBI System
for the Unified Management, Assessment and Review of Information
(SUMARI)(5). Any disagreements between the reviewers were resolved through
discussion or with a third reviewer (LG). Following critical analysis, studies that did
not meet a certain quality threshold were excluded. The decision to exclude was
based on cut-off scores of less than 70% of the items assessed for all JBI critical
appraisal tools. This represents the following checklist amount of ‘‘yes’’ answers:
fewer than seven out of 10 for case-control studies and fewer than five out of

eight for analytical cross-sectional studies. The results of critical appraisal were
reported in (Table 2).
Data extraction
Data extracted from studies were included in the review using the standardized
Joanna Briggs Institute data extraction tool. The data extracted include specific
details about the authors, year of study enrolment, country of origin, outcome
analysed in the individual studies, details about populations, study methods and
interventions. Findings, and their illustrations, were extracted and assigned a level
of credibility (Table 3&4).
Data Synthesis
Qualitative research findings were pooled using the meta-aggregation approach.
Thematic analysis was used to synthesize findings and a narrative approach was
used to present findings in accordance with the JBI guidelines using the Joanna
Briggs Institute’s guidelines and using the software SUMARI – The System for the
Unified Management, Assessment and Review of Information. Only unequivocal
and credible findings were included in the synthesis. The results of qualitative
synthesis were presented in a narrative form including tables and figures (Table 3)
and (Figure 2) to aid in data presentation.
Assessing confidence in the findings
The final synthesized findings were graded according to the GRADE‐CERQual
approach (6) by two independent reviewers (FA and LG) for establishing
confidence in the output of qualitative research synthesis and presented in a
Summary of Findings (Table 1). The Summary of Findings includes the major
elements of the review and details how the GRADE‐CERQual score was

developed. Included in the table is the title, population, phenomena of interest,
and context for the specific review. Each synthesized finding from the review is
presented, along with the type of research informing it, scores for methodological
limitations, coherence, relevance, adequacy, and the overall GRADE‐CERQual
score.
Results
Study inclusion
From a total of 1064 database hits, six studies of various methodologies fulfilled
the inclusion criteria for this review: two cross-sectional studies and four casecontrolled studies. The remaining of the studies were excluded, and reasons of
exclusion were reported in the PRISMA flow chart (Figure1). A total of six articles
underwent quality assessment, and no articles were excluded following
assessment of methodological quality. A final total of six studies was included in
the review.
Methodological quality
All six studies included are observational studies. Two were cross-sectional
studies (7)and (8), and four were case-control studies (9), (10), (11)and (12).
Overall, the methodological quality of included studies was considered good and
there were no studies that were excluded following critical appraisal when
assessed using the standard Joanna Briggs Institute Critical Appraisal Checklist for
Qualitative Research using JBI (SUMARI). (Table 2).

Characteristics of included studies
The included studies were conducted between 2013 and 2019. Two were cross sectional studies undertaken in Spain(7) and South Korea (8). Four were case
controls studies undertaken in Naples (9), Italy (10), Korea (11), and Iran (12). All
studies used qualitative descriptive methodologies to assess sleep disturbances in
patients diagnosed with BMS. Data collection was based on self- reported
validated sleep questionnaires given to patients attending oral medicine clinics.
All the six included studies used The Pittsburgh Sleep Quality index (PSQI) and
four of these studies used The Epworth Sleepiness Scale (ESS)in addition to the
PSQI. Patients from both control and study groups were matched for sex and
gender in all studies except in two studies that had more female patients (10) and
(8). All studies recruited patients from single university oral medicine clinics
setting except one that was undertaken in ten oral medicine units of different
universities across the country (10). The BMS group inclusion criteria in all
included studies was in accordance with the International Classification of
Headaches(13) and the total number of participants drawn from the included
studies was 856. Table 4 outlines the characteristics of included studies.
Review findings
The review included six studies to evaluate if patients with BMS are more prone
to have sleep disturbances. In the selected studies, the dimensions of sleep were
assessed using the Pittsburgh Sleep Quality Index (PSQI) and the Epworth
Sleepiness Scale (ESS). The PSQI is a self-reported questionnaire (subjective)
consisting of 19 questions correlating to seven domains: subjective sleep quality,
sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of

sleep medication and daytime dysfunction. Each domain is given a direct score of
0–3. A score of zero indicates no problem in this domain, while three indicates a
serious problem. The sum of the seven scores gives an overall score of 0–21. A
PSQI total of <5 is the threshold for subjects classified as satisfactory sleepers,
while a patient with a score of >5 can be considered as suffering sleep
disturbance (14). The Epworth daytime sleepiness scale (ESS) determines or
measures daytime sleepiness by means of eight items. The subject is questioned
as to the frequency (or probability) of falling asleep on a scale of 1–3 in eight
different situations that most people experience in daily life such as sitting and
reading, watching TV, sitting, inactive in public place, as a passenger in a car for an
hour without a break, lying down to rest in the afternoon when circumstances
permit, sitting and talking to someone, sitting quietly after a lunch without
alcohol, in a car, while stopped for a few minutes in the traffic. The eight items
are totaled to give an overall score of 0–24, with higher scores indicating greater
sleepiness during common daily activities. A score of 0–9 is considered normal, A
score of 11–15 indicates the possibility of slight to moderate sleep apnea, while a
score of over 16 indicates severe sleep apnea or narcolepsy (15). The assessment
of the dimensions of sleep affected resulted in six synthesized findings: 1) BMS
patients have more rates of sleep disturbance than controls; 2) BMS patients have
less sleep duration rates than controls; 3) BMS patients have higher rates of
daytime dysfunction than controls; 4) BMS patients have lower sleep quality than
controls; 5) BMS patients have more difficulty falling asleep than controls; and 6)
BMS patients have lower sleep efficiency than controls. The six synthesized
findings were rated using the GRADE‐CERQual approach (6).

Synthesized finding 1: BMS patients have more rates of sleep disturbance than
controls
Six studies used (PSQI) to assess sleep disturbance and duration (7), (8), (9), (10),
(11), and (12). Outcome consistent evidence from above six studies of (moderate
confidence of evidence) found that BMS patients have significantly higher rates of
sleep disturbance than controls.
Synthesized finding 2: BMS patients have less sleep duration rates than controls
Two of the included studies, (8) and (10) found significantly lower rates of sleep
duration in BMS patients compared to controls (low confidence level of evidence).
Synthesized finding 3: BMS patients have higher rates of daytime dysfunction
than controls
Of the six studies used (PSQI) and four studies used (ESS), four reported daytime
dysfunctions in the BMS groups using PSQI questionnaire (10), (8) (9) (11). Four
studies reported significantly more daytime dysfunction in BMS group using ESS
scale (7), (9), (10), and (11). Outcome Consistent evidence from five (moderate
confidence level of evidence) studies found that poor sleep was adversely
associated with day-time function in BMS patients.
Synthesized finding 4: BMS patients have lower sleep quality than controls
Six studies used (PSQI) to subjectively measure sleep quality. All these six studies
(moderate confidence level of evidence) showed significantly low sleep quality in
BMS groups when compared to controls (9), (10), (11), (12), (8), and (7).

Synthesized finding 5: BMS patients have more difficulty falling asleep than
controls
Six studies (moderate confidence level of evidence) used (PSQI) to measure sleep
latency and four concluded that BMS patients have significant difficulty in falling
asleep when compared to controls (7), (9), (10), and (8).
Synthesized finding 6: BMS patients have lower sleep efficiency than controls
Six studies (moderate confidence level of evidence) used (PSQI) to measure sleep
efficiency, which was significantly lower in the BMS groups in four of these studies
(7), (9), (10), and (8).
Summary
Overall, consistent evidence from various (six) studies [moderate confidence
level] suggests that BMS patients have greater sleep disturbance compared with
controls, and consistent evidence from four studies [moderate confidence], found
that BMS patients have greater difficulty falling asleep compared with controls.
Quality of life and function were also assessed in these studies; and consistent
evidence from most studies [moderate confidence] found that poor sleep in BMS
patients is associated with poorer day-time function (five studies) and sleep
quality (six studies) when compared with controls. Similarly, evidence from four
studies [moderate confidence] found that BMS patients suffer from reduced sleep
efficiency compared with controls. Lastly, consistent evidence from two studies
[low confidence level] found that BMS patients have less sleep duration than
controls.

Discussion
This review examined the association between BMS and various dimensions of
sleep. Although we only identified 6 studies that fit the search criteria, and
variability across studies may limit full assessment for agreement in systematic
reviews, in our search most studies were conducted at a single center university
based oral medicine clinics, except one study that included multi-oral medicine
clinics from 10 universities across the country (10); thus some correlations were
found across studies, including similar assessments and scales that were used to
measure sleep disturbance. Studies were particularly aged and sex matched, with
the exception of two studies that included greater than 75% of female subjects
(10) (8). These findings corroborate with previous reported research in BMS that
shows BMS being most prevalent in postmenopausal females.
Overall, there was substantial evidence that BMS is associated with sleep
disturbances, but a causal relationship could not be found due to the
observational nature of included studies and lack of additional studies designed as
controlled, interventional trials. Most of the included studies involved small
sample size, and had resource limited settings (e.g., did not represent the general
population, presented heterogeneity of study statistical methods and methods of
reporting results) which contributed to the lack of stronger evidence. Also, due to
the natural absence of randomization and blinding in observational studies and
low sample sizes, many studies received a lower confidence in the overall
CERQual assessment score. One strength of our findings was the fact that all
qualified studies under our criteria used similar pain level and sleep disturbances
validated questionnaires. These validated questionnaires allowed for the
assessment of several dimensions of “sleep” with results showing that most of

them are found to be impaired in BMS patients when compared with controls
(i.e., sleep duration, sleep disturbance, daytime function, sleep quality, and ability
to fall asleep and sleep efficiency).
Assessment of sleep can be subjective; for example, the results of valid and
reliable questionnaires, such as Pittsburgh Sleep Quality Index (PSQI), reported by
patients. Whereas objective assessment of sleep require the use of complex and
expensive measures such as polysomnography (PSG), that require the
simultaneous assessment of brain activity, eye movement, and muscle activity (4).
This review includes only subjective measurements of sleep disturbances in BMS
patients and future studies should use objective measurment tools to adjunct the
self-reported subjective assessment tools such as use of electronic daily diaries,
PSG, and actigraphy to provide an accurate measure of overall sleep disturbance.
Such studies would allow for a better understanding of this condition of
multifactorial origin that is mostly idiopathic, and its etiopathogenesis remains
largely unknown.
Clinically, in patients with BMS, it is often challenging to isolate one etiological
factor aggravating symptoms of BMS and it is unclear whether sleep disturbance
is a cause, or an effect of chronic pain. This was exemplified in previous studies of
BMS where about 23% of chronic pain patients reported at least one insomnia
symptom, whereas 40% of insomnia patients reported at least one chronic pain
condition (16). Sleep disturbance also can affect individual’s response to pain, and
experimentally induced sleep deprivation studies enrolling a healthy pain-free
population, has reportedly resulted in heightened pain perception, reduced pain
tolerance and pain thresholds (17). In our search, BMS was found to relate to

several dimensions of sleep including sleep disturbance and duration, sleep
affecting day-time function, sleep quality, sleep efficiency, and ability to fall
asleep. This association was also reported in a retrospective population-based
cross-sectional study on 47,941 Taiwanese patients with apnea and non-apnea
sleep disorders. This study concluded that poor sleep increases the risk of BMS,
indicating the important role of sleep disturbances in BMS (18). Although it is
generally assumed that psychcosocial comorbidities such as depression and
anxiety in BMS patients are the cause of sleep disturbances, recent accumulative
evidence implies that primary sleep disorders should be considered as separate
comorbidity and treating sleep disturbances can improve quality of life in these
patients even in abscence of a confirmed diagnosed of depression and/or anxiety
(19).
Conclusion
Given the disabling nature of BMS, it is of great importance to identify effective
methods of treatment. Due to the limited number of controlled clinical trials with
low risk of bias, there is lack of evidence to support or refute the use of any
interventions in managing BMS as a direct cause of sleep disturbance. Further
clinical trials, with standardized methodology and reproducible outcomes are
required for better understanding of the etiological and psychological nature of
this disorder. This study supports what previous studies had concluded that as
with other chronic orofacial pain disorders, BMS patients have an increased risk in
developing sleep disturbances than the general population and both subjective
and objective sleep assessment tools are needed in future studies to assess such
comorbidities and to help in the development of targeted and more precise
pharmacological and non-pharmacological interventions for management of this

painful and often frustrating condition. Ultimately, an interdisciplinary and
systematic approach is required for diagnosis and management of BMS patients
who are mostly treated by oral medicine specialists. Yet these cases should
include evaluation of other comorbidities associated with the condition, including
sleep disturbances. Medications and other management strategies to improve
sleep may also be considered in future research for managing BMS patients. In
conclusion, although the presented studies could not establish a causal
relationship between BMS and sleep disturbances it shows that patients with BMS
have more risk in developing sleep disturbance that in turn can aggravate their
symptoms.
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Appendix I:
Search strategy:
PubMed:
((("Hypnotics and Sedatives"[Mesh] OR sedatives OR "sleep medicine" OR
"Hypnotics and Sedatives" [Pharmacological Action] OR "GABA
Modulators"[Mesh] OR "GABA Modulators" [Pharmacological Action] OR "GABA
Plasma Membrane Transport Proteins"[Mesh] OR "Barbiturates"[Mesh] OR sleep
OR "Sleep Wake Disorders"[Mesh] OR "Sleep"[Mesh] OR sedative or sedatives OR
sleep-wake OR insomnia OR barbiturates OR hypnotic OR GABA ) AND ( "Burning
Mouth Syndrome"[Mesh] OR "Burning mouth syndrome- Type 3" [Supplementary
Concept] OR glossodynia OR "Stomatodynia"[Supplementary Concept] OR
orodynia OR oral dysaesthesia OR glossopyrosis OR stomatodynia OR burning
tongue OR stomatopyrosis OR sore tongue OR burning tongue syndrome OR
burning mouth OR sore mouth)))
Embase:

('hypnotic sedative agent'/exp OR 'sedative agent'/exp OR 'sedative agent'/exp
OR 'sleep medicine'/exp OR 'benzodiazepine receptor affecting agent'/exp OR '4
aminobutyric acid carrier'/exp OR 'insomnia'/exp OR 'sleep induction'/exp OR
'sleep disorder'/exp OR 'sleep'/exp OR Sleep OR sedative or sedatives OR sleepwake OR insomnia OR barbiturates OR hypnotic OR GABA) AND ('burning mouth
syndrome'/exp OR 'glossodynia'/exp OR 'mouth pain'/exp OR glossodynia OR
orodynia OR 'oral dysaesthesia' OR glossopyrosis OR stomatodynia OR 'burning
tongue' OR stomatopyrosis OR 'sore tongue' OR 'burning tongue syndrome' OR
'burning mouth' OR 'sore mouth' OR Glossalgia)
Scopus:
( ( glossodynia OR orodynia OR "oral dysaesthesia" OR glossopyrosis OR
stomatodynia OR "burning tongue" OR stomatopyrosis OR "sore tongue" OR
"burning mouth" OR "sore mouth" OR glossalgia ) AND ( Sleep OR sedative or
sedatives OR sleep-wake OR insomnia OR barbiturates OR hypnotic OR GABA ))
Cochrane:
1. Mesh Description: "Burning Mouth Syndrome"[Mesh] explode all trees
2. Mesh Description: “Glossalgia” [Mesh] explode all trees
3. ( glossodynia OR orodynia OR "oral dysaesthesia" OR glossopyrosis
OR stomatodynia OR "burning tongue" OR stomatopyrosis OR "sore
tongue" OR "burning mouth" OR "sore mouth" OR Glossalgia)
4. Mesh Description: "Sleep"[Mesh] explode all trees
5. Mesh Description: "Sleep Wake Disorders"[Mesh] explode all trees
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